• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

mPATH Health Secures $3M to Enhance Cancer Screening and Equity

by Syed Hamza Sohail 10/24/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– mPATH® Health, a digital health company dedicated to improving cancer screening, is thrilled to announce the successful closure of $3 million in funding, which will accelerate the company’s mission to enhance cancer prevention and improve health equity.

– This funding includes a $2 million Small Business Technology Grant from the National Cancer Institute (NCI) and a $1 million equity investment led by Oncology Ventures, an oncology-focused venture capital firm.

mPATH Health Secures Funding to Enhance Cancer Screening and Prevention Programs

mPATH Health, a digital health company dedicated to revolutionizing preventive cancer screening through automation and behavioral science, has received a significant boost in its mission to improve early cancer detection. By utilizing advanced technology and personalized outreach, mPATH empowers individuals to prioritize their health and undergo routine cancer screenings. The platform’s unique approach has proven effective in doubling screening rates across diverse populations, including those of different races, ethnicities, income levels, and literacy backgrounds.

In July 2024, mPATH Health was awarded a National Cancer Institute (NCI) grant to support the commercialization of its innovative cancer screening program. This funding will enable continued development and rigorous clinical testing of the platform, further validating its ability to increase cancer screening rates in underserved communities.

– The NCI grant, a pivotal endorsement of mPATH’s technology, will be instrumental in advancing the platform’s effectiveness across various demographic groups.

Additionally, mPATH Health secured $1 million in funding from Oncology Ventures, an investment firm dedicated to improving cancer care access, outcomes, and cost-efficiency. This investment will accelerate mPATH’s growth and facilitate the development of new screening and preventive health modules.

– With this financial support, mPATH Health is well-positioned to expand its reach and impact, promoting health equity by delivering improved outcomes for patients from all backgrounds.

These milestones mark a pivotal moment in mPATH Health’s journey to transform cancer prevention, ensuring broader access to life-saving screenings and empowering individuals to take charge of their health.


“We are incredibly proud of the recognition from the NCI and the investment from Oncology Ventures,” said Dr. David Miller, co-founder of mPATH. “This $3 million funding will allow us to rapidly expand our reach, increase cancer screenings, and ultimately save lives. It will also enhance our program and ensure that we can document its return on investment for health systems and insurers.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |